AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Neighborhood socioeconomic deprivation is independently linked to worse follow-up adherence for incidentally found pulmonary nodules.

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

A psychoeducational intervention for extrapulmonary manifestations of severe asthma was found feasible and rated as ...

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on PLRX stock, giving a Buy rating on January 15.Stay Ahead of ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.